Referring to the bulletin from Mendus AB's annual general meeting, held on May 17, 2024, the company will carry out a reverse stock split in relations 1:20. The share will be traded under new ISIN code with effect from Jun 3, 2024. The order book will not change. Short name: IMMU Terms: Reverse split: 1:20 Current ISIN: SE0005003654 Last day of trading with current ISIN code: May 31, 2024 New ISIN code: SE0022239950 First day of trading with new ISIN code: Jun 3, 2024
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.11. | Mendus AB: Mendus AB Interim Report January - September 2024 | Press ReleaseStockholm, Sweden, November 8, 2024"In the third quarter of 2024, Mendus has focused on expanding the clinical development for vididencel in acute myeloid leukemia (AML) and progressing... ► Artikel lesen | |
| 27.08. | Mendus - Broad progress across the pipeline | Mendus's Q224 results reflect a period of steady progress across its clinical programmes. For vididencel, the Phase II CADENCE trial (for acute myeloid leukaemia, AML) is now ready to commence patient... ► Artikel lesen | |
| 23.08. | Mendus AB: Mendus AB Interim Report January - June 2024 | Press ReleaseStockholm, Sweden, August 23, 2024Data Reported in Q2 Confirm that Vididencel Acts as Active Immunotherapy in AMLIn the second quarter of 2024, Mendus reported in-depth immunological data... ► Artikel lesen | |
| 24.07. | Mendus - Collaboration unveils path forward for ilixadencel | Mendus has announced a collaboration with Institut Bergonié, an established comprehensive cancer centre in France, to test ilixadencel in soft tissue sarcomas (STS) as part of an ongoing Phase I/II... ► Artikel lesen | |
| 03.06. | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 03.06.2024 | The following instruments on XETRA do have their first trading 03.06.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 03.06.2024
Aktien
1 US0071921078 Admiral Group PLC ADR
2... ► Artikel lesen |
